Vonage IPO Smells Like Bait

As the news reports of Vonage's IPO plans bubble and froth, the guess here is that the Voice over IP leader won't ever make it to the public markets, but will be acquired first. Just call the carefully leaked IPO...

August 25, 2005

1 Min Read
NetworkComputing logo in a gray background | NetworkComputing

As the news reports of Vonage's IPO plans bubble and froth, the guess here is that the Voice over IP leader won't ever make it to the public markets, but will be acquired first. Just call the carefully leaked IPO news a bit of bait, to lure the big fishes into striking now. Someone buying Vonage isn't a new idea -- Russell Shaw, for one, advanced reasons for Sprint buying Vonage way back in April -- but it's one that Vonage would like to accelerate now, while mindshare over VoIP is hot and details of Vonage's business can be overlooked.

If Vonage were truly in the VoIP business for the long haul, it might have spent less of its VC stash on marketing and more on research and development (or maybe even acquisitions) of interesting IP-based applications that would have let Vonage move away from its initial strategy of offering just low-cost telephone replacement services.

From here, an IPO looks dubious since it's going to take a lot more than the $600 million Vonage is reportedly seeking to successfully battle the SBCs and Verizons of the world, who now have their regulatory lapdogs taking big bites out of Vonage's market lead. Just ask Covad or Northpoint or Rhythms how long VC money lasts against an RBOC determined to drum you out of business.

However Vonage's independence story ends, it should always be remembered that the company was one of the leaders in showing the world that we didn't have to accept the Ma Bell method of voice-call pricing. For helping to shatter that myth forever, Vonage CEO Jeffrey Citron and his co-workers (and investors) certainly deserve some reward, even if it stops short of a NASDAQ symbol.

Read more about:

2005
SUBSCRIBE TO OUR NEWSLETTER
Stay informed! Sign up to get expert advice and insight delivered direct to your inbox

You May Also Like


More Insights